Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Ralph Weissleder

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-0828-4143; OpenAlex author ID A5067255019; NIH RePORTER profile ID 1887033. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
7
Labs led
3
Collaborators
56
Papers, trials and grants by year

2013: 2 papers · 2014: 1 grant · 2015: 2 papers, 1 grant · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 grant · 2022: 1 paper · 2023: 1 grant · 2024: 1 paper, 1 grant · 2025: 1 paper, 1 grant · 2026: 2 papers, 1 grant

Papers 9

  1. Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer. Last author DOI 10.1016/j.xcrm.2026.102938↗
  2. Therapeutic Targeting of Epithelial-Mesenchymal Cellular Plasticity in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-25-2052↗
  3. The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancer Co-author DOI 10.1101/2025.08.26.672505↗
  4. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment. Co-author DOI 10.1038/s41588-024-01890-9↗
  5. Single-EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer. Last author DOI 10.1126/sciadv.abm3453↗
  6. The use of 18F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer. Co-author DOI 10.1021/acscentsci.5b00121↗
  7. Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-1591↗
  8. Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection. Last author DOI 10.1593/neo.13276↗
  9. Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle. Co-author DOI 10.1593/tlo.13400↗

Grants 7

  1. Pancreatic cancer patient-derived xenograft tumors for translational studies in precision cancer medicine R01CA293063↗
  2. Core C-Computational Core P01CA117969↗
  3. Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) R01CA237332↗
  4. Project 3 - Improving Therapy for DNA-Damage Deficient Pancreatic Adenocarcinoma P50CA127003↗
  5. Single Circulating Vesicle Analysis for Early Cancer Detection R21CA236561↗
  6. BIND Chemistry for Imaging Intracellular Targets P50CA086355↗
  7. The Development of Clinical Grade, Targeted Magnetic Nanoparticles U54CA151884↗

Closest collaborators

The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Scott Liss · 2 shared papers, 1 shared grant, 2022–2026 · strength 1.68
  2. Tyler Jacks · 2 shared papers, 1 shared grant, 2024–2025 · strength 0.75
  3. Brian Matthew Wolpin · 1 shared grant, 2023 · strength 0.61
  4. Charles S. Fuchs · 1 shared grant, 2023 · strength 0.61
  5. David Tsai Ting · 3 shared papers, 2024–2026 · strength 0.50
  6. William L. Hwang · 3 shared papers, 2024–2026 · strength 0.50
  7. Sarah P. Thayer · 1 shared paper, 1 shared grant, 2013–2025 · strength 0.49
  8. Ronald Anthony Depinho · 1 shared paper, 1 shared grant, 2013–2025 · strength 0.48
  9. Cyril Henri Benes · 1 shared grant, 2025 · strength 0.45
  10. Gerald C Chu · 1 shared grant, 2025 · strength 0.45
  11. Phillip Andrew Futreal · 1 shared grant, 2025 · strength 0.45
  12. NABEEL El-BARDEESY · 1 shared grant, 2025 · strength 0.45
  13. Lewis C. Cantley · 1 shared grant, 2025 · strength 0.45
  14. Raghu Kalluri · 1 shared grant, 2025 · strength 0.45
  15. Anirban Maitra · 1 shared grant, 2025 · strength 0.45
  16. James wesley Horner · 1 shared grant, 2025 · strength 0.45
  17. Huamin Wang · 1 shared grant, 2025 · strength 0.45
  18. Mari A. Mino-Kenudson · 3 shared papers, 2013–2025 · strength 0.35
  19. Theodore Sunki Hong · 2 shared papers, 2024–2025 · strength 0.30
  20. Nicholas J Caldwell · 2 shared papers, 2024–2025 · strength 0.30
  21. Dennis H. Gong · 2 shared papers, 2024–2025 · strength 0.30
  22. Carina Shiau · 2 shared papers, 2024–2025 · strength 0.30
  23. Jimmy A. Guo · 2 shared papers, 2024–2025 · strength 0.30
  24. Hannah Johnson Roberts · 2 shared papers, 2024–2025 · strength 0.30
  25. Jennifer Yon-Li Wo · 2 shared papers, 2024–2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.